X2H20R9
Insertion Femoral Vein, Right to New Technology Group 9 with Intraluminal Device, Bioprosthetic Valve, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | H Insertion |
| Body Part | 2 Femoral Vein, Right |
| Approach | 0 Open |
| Device | R Intraluminal Device, Bioprosthetic Valve |
| Qualifier | 9 New Technology Group 9 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family covers implanting a nonbiological device into the heart or a blood vessel that monitors or supports a physiological function without replacing any tissue itself. A common example is a leadless cardiac pacemaker, a self-contained capsule placed directly inside a heart chamber through a catheter rather than through a surgically implanted pulse generator with wire leads. The device senses the heart's electrical activity and delivers pacing impulses as needed, addressing slow or irregular heart rhythms.
Because the New Technology section exists to track devices recently approved for distinct reimbursement and outcomes monitoring, these procedures are typically newer catheter-based alternatives to long-established open or lead-based techniques. Patients considering them are often candidates who face higher risk from traditional lead placement, such as those with prior infections or difficult venous access.
Anatomy & Axis Detail
Femoral Vein, Right
The right femoral vein, running alongside the femoral artery in the groin, is a familiar access point for introducing catheter-based devices because it is large, superficial, and compressible, allowing percutaneous entry without a surgical cutdown in most cases. When a device is inserted here as a distinct procedure rather than as a pathway to advance equipment elsewhere, it typically remains within the vein itself, such as a filter or sensor positioned in the venous circulation of the lower body. The right-sided approach is often chosen based on operator preference, prior instrumentation of the contralateral side, or specific anatomic considerations seen on imaging. Because this vein drains a large territory of the leg and pelvis, care is taken to avoid occluding flow, and postprocedural monitoring focuses on the groin site and distal leg for signs of venous compromise.
Approach: Open
Open approach in New Technology denotes access to the target site through a surgical incision that exposes the body part directly to view and instrumentation. It stands apart from percutaneous and endoscopic approaches, which achieve access through small punctures or existing openings rather than a deliberate surgical opening of tissue.
Device / Substance / Technology: Intraluminal Device, Bioprosthetic Valve
This value identifies a bioprosthetic heart valve delivered and seated within an existing vascular or valvular lumen, most familiar as the replacement valve used in transcatheter valve procedures. It is distinguished from mechanical or surgically sutured valve prostheses by its catheter-based, intraluminal placement technique. The value applies to the valve itself rather than to adjunct technologies like leaflet-splitting devices used alongside it.
Qualifier: New Technology Group 9
Group 9 is the seventh-position qualifier used in the New Technology section to mark a device, substance, or technique as belonging to the 2022 annual cohort of new technology add-on codes. It has no clinical meaning of its own beyond that vintage tag, so coders rely on the specific table and body system to know what procedure it applies to. It is distinguished from Group 8 and Group 10 purely by the fiscal year the technology was approved for separate identification.
Coding & Documentation
Coders need the operative note to confirm the specific brand or device named in the New Technology table entry, since these codes are device-specific rather than generic. Documentation should state the approach (typically percutaneous), the target chamber, and confirmation that the device itself performs the monitoring or assistive function rather than serving as a structural replacement. A frequent error is defaulting to the standard Cardiovascular section code for pacemaker or device insertion instead of checking whether the specific model qualifies for a New Technology designation, which can materially change reimbursement. Another common miss is failing to update code selection when a device's New Technology group value changes between annual code set updates.
Commonly Confused With
This is easily confused with standard Insertion procedures coded in the regular Cardiovascular System section, where the distinguishing factor is solely whether the device brand appears in the New Technology reference table for that year. It is also distinct from Replacement, which applies when the device or material takes over the physical role of a body part rather than simply monitoring or assisting it.